AKT1 and cancer: In addition to modulating RORγ signaling, CGs influence key intracellular pathways, including NF-κB, PI3K/Akt, and JAK/STAT, highlighting their potential therapeutic utility in autoimmune diseases, chronic inflammatory disorders, and cancer-associated immune dysregulation [210,277].